Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk

Joint Authors

Zhang, Jianye
Wang, Junjie
Tang, Yingying
Zhang, Tianhong
Cui, Huiru
Xu, Lihua
Zeng, Botao
Li, Yu
Li, Gaiying
Li, Chunbo
Liu, Hui
Lu, Zheng
Wang, Jijun

Source

Neural Plasticity

Issue

Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-9, 9 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2016-11-28

Country of Publication

Egypt

No. of Pages

9

Main Subjects

Biology
Medicine

Abstract EN

Altered γ-aminobutyric acid (GABA), glutamate (Glu) levels, and an imbalance between GABAergic and glutamatergic neurotransmissions have been involved in the pathophysiology of schizophrenia.

However, it remains unclear how these abnormalities impact the onset and course of psychosis.

In the present study, 21 drug-naïve subjects at ultrahigh risk for psychosis (UHR), 16 drug-naïve patients with first-episode schizophrenia (FES), and 23 healthy controls (HC) were enrolled.

In vivo GABA and glutamate+glutamine (Glx) levels in the medial prefrontal cortex were measured using proton magnetic resonance spectroscopy.

Medial prefrontal GABA and Glx levels in FES patients were significantly lower than those in HC and UHR, respectively.

GABA and Glx levels in UHR were comparable with those in HC.

In each group, there was a positive correlation between GABA and Glx levels.

Reduced medial prefrontal GABA and Glx levels thus may play an important role in the early stages of schizophrenia.

American Psychological Association (APA)

Wang, Junjie& Tang, Yingying& Zhang, Tianhong& Cui, Huiru& Xu, Lihua& Zeng, Botao…[et al.]. 2016. Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk. Neural Plasticity،Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1113114

Modern Language Association (MLA)

Wang, Junjie…[et al.]. Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk. Neural Plasticity No. 2016 (2016), pp.1-9.
https://search.emarefa.net/detail/BIM-1113114

American Medical Association (AMA)

Wang, Junjie& Tang, Yingying& Zhang, Tianhong& Cui, Huiru& Xu, Lihua& Zeng, Botao…[et al.]. Reduced γ-Aminobutyric Acid and Glutamate+Glutamine Levels in Drug-Naïve Patients with First-Episode Schizophrenia but Not in Those at Ultrahigh Risk. Neural Plasticity. 2016. Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1113114

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1113114